Asia-Pacific pen needles market is projected to register a healthy CAGR in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Market Segmentation:
By Product Type (Standard Pen Needles, Safety Pen Needles), Product Length (Medium Length, Nano Length, Long Length), Usability (Disposable, Reusable), Application (Diabetes, Growth Hormone Deficiency, Others), Therapy (Insulin, Glucagon-Like Peptide-1, Growth Hormones, Others), End User (Home Healthcare, Hospitals, Clinics, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific)
Some of the major factors contributing to the growth of Asia-Pacific pen needles market:
Increasing number of diabetes patient base
Increasing government initiative for pen needles
Market Players:
The key market players for Asia-Pacific pen needles market are listed below:
> Novo Nordisk A/S
> Eli Lilly and Company
> Terumo Corporation
> MedExel Co., Ltd
> ALLISON MEDICAL
> VOGT MEDICAL
> Digital Medics Pty Ltd.
> STAT Medical Devices.
> DOMREX Pharma Inc.
> Menarini Diagnostics srl
> Ypsomed AG
> Braun Melsungen AG
> Facet Medical Technologies
> KD Medical GmbH
> Haselmeier GmbH & Co. KG
> pendiq GmbH
> MedExel Co., Ltd
> Owen Mumford Ltd.
> HTL-STREFA S.A.
> LDI, Ltd. LLC
> Sanofi